SB0514: A BILL FOR AN ACT to amend the Indiana Code concerning insurance.
Page last updated: Sunday, April 20, 2025 at 8:01 PM (America/Indianapolis).
General Information
- Stage: Introduced Senate Bill (S)
- Current Chamber: senate
- Origin Chamber: senate
- Description: Chimeric antigen receptor T-cell therapy.
Legislators
Authors (1)
Coauthors (0)
Sponsors (0)
Cosponsors (0)
Advisors (0)
Conferees (0)
Actions (2 total)
- Jan 16, 2025, 9:13 AM: First reading: referred to Committee on Health and Provider Services
- Jan 16, 2025, 9:13 AM: Authored by Senator Leising
Digest
Provides that a policy of accident and sickness insurance or health maintenance organization contract that provides coverage for chimeric antigen receptor (CAR) T-cell therapy may not refuse to contract or deny coverage for the administration of any CAR T-cell therapy by any provider that qualifies as a certified health care facility by the federal Food and Drug Administration for the applicable CAR T-cell therapy.